In October 2024, NASA’s Office of the Chief Health and Medical Officer (OCHMO) initiated a working group to review the status and progress of research and clinical activities intended to mitigate the risk of venous thromboembolism (VTE) during spaceflight. The working group took place over two days at NASA’s Johnson Space Center; a second meeting … Read more
NASA’s Office of the Chief Health and Medical Officer (OCHMO) assembled a small working group to review hydrogen sulfide (H2S) Spacecraft Maximum Allowable Concentration (SMAC) values. The group met virtually three times during February and March 2023, and panel members submitted individual opinion statements in April 2023. Toxicology subject matter experts were chosen to result … Read more
In June 2024, the NASA Office of the Chief Health and Medical Officer (OCHMO) Standards Team hosted an independent assessment working group to review the status and progress of research and clinical activities intended to mitigate the risk of decompression sickness (DCS) related to patent foramen ovale (PFO) during spaceflight and associated ground testing and … Read more